Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA: Tysabri risks greatest during year 3
FDA: Tysabri risks greatest during year 3
FDA: Tysabri risks greatest during year 3
Submitted by
admin
on April 26, 2011 - 6:21am
Source:
Fierce Pharma
News Tags:
FDA
Biogen Idec
Tysabri
MS
multiple sclerosis
Headline:
FDA: Tysabri risks greatest during year 3
Do Not Allow Advertisers to Use My Personal information
